CCM
SRPT icon

Cinctive Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Cinctive Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
+48,855
New +$924K 0.03% 333
2024
Q3 		– Sell
-29,129
Closed -$4.6M – 508
2024
Q2 		$4.6M Sell
29,129
-49,231
-63% -$6.32M 0.22% 158
2024
Q1 		$10.1M Buy
+78,360
New +$9.6M 0.47% 63
2022
Q1 		– Sell
-13,300
Closed -$1.2M – 650
2021
Q4 		$1.2M Buy
+13,300
New +$1.14M 0.05% 380

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cinctive Capital Management's SRPT Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 48,855 shares worth $878K. The stake represents 0.03% of the portfolio and ranks #333 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in SRPT as recently as Q2 2024.

Cinctive Capital Management first reported a position in SRPT in Q4 2021 and has held it in 4 quarters since. The position peaked at $10.1M in Q1 2024. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Cinctive Capital Management held 48,855 shares of Sarepta Therapeutics worth $878K as of Q2 2026.
  • Sarepta Therapeutics was a new Cinctive Capital Management position in Q2 2026.
  • Sarepta Therapeutics made up 0.03% of Cinctive Capital Management's portfolio in Q2 2026, its #333 holding.
  • Cinctive Capital Management first reported a position in Sarepta Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • Cinctive Capital Management's Sarepta Therapeutics position peaked at $10.1M in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.